SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines. Shen et al. Supplemental Tables S1, S2, S3
Published: 25 February 2021| Version 1 | DOI: 10.17632/ty33r9g972.1
Contributor:
Xiaoying ShenDescription
Supplemental Tables S1, S2, S3.
Files
Institutions
Duke University
Categories
Immunology, Vaccine, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19